The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Open accessAbstract
The amyloid A4 or beta peptide is a major component of extracellular amyloid deposits that are a characteristic feature of Alzheimer's disease. We synthesized a series of peptide analogs of the A4/beta peptide which are progressively longer at their carboxyl termini, including 42- and 39-residue peptides which represent the major forms of the A4/beta peptide in senile plaque and the hereditary cerebral hemorrhage with amyloidosis form, respectively. All peptides tested, beta 1-28 through beta 1-42, formed amyloid-like fibrils and previously unreported thin sheet-like structures which stained with thioflavin T and Congo Red. The solubility of beta 1-42 and shorter peptides was pH and concentration dependent, with a broad insolubility profile in the pH range of 3.5-6.5 and at concentrations above 0.75 mg/ml. Only peptides of 42 residues or longer were significantly insoluble at pH 7.4. beta 1-47 and beta 1-52 peptides are highly insoluble in aqueous media but are soluble at 40 mg/ml in the alpha helix-promoting solvent, 1,1,1,3,3,3-hexafluoro-2-propanol. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that the beta 1-42 peptide migrates as a series of higher molecular mass aggregates whereas shorter peptides migrate as monomers. Aggregation is also dependent on pH, peptide concentration, and time of incubation in aqueous medium. These results indicate that the length of the hydrophobic carboxyl terminus of the A4/beta peptide is important in determining the s…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A{31-42 has been shown to form insoluble amyloid fibrils more rapidly than A{31-40 (10)(11)(12)(13).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [11]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity
Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., & Ito, H. (1988) · Nature · doi:10.1038/331530a0 · Cited by 1,083
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction
Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,066
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors
Ponte, P. A., Gonzalez‐DeWhitt, P. A., Schilling, J., Miller, J., Hsu, D. K., Greenberg, B., Davis, K. L., Wallace, W., Lieberburg, I. M., Fuller, F. H., et al. (1988) · Nature · doi:10.1038/331525a0 · Cited by 1,050
Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
Hilbich, C., Kisters–Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. T. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580
Kirschner, D. A., Abraham, C. R., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.503 · Cited by 570
Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition
Barrow, C. J., & Zagorski, M. G. (1991) · Science · doi:10.1126/science.1853202 · Cited by 538
Kirschner, D. A., Inouye, H., Duffy, L. K., Sinclair, A. J., Lind, M., & Selkoe, D. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6953 · Cited by 481
Amyloid β Protein Enhances the Survival of Hippocampal Neurons in Vitro
Whitson, J. S., Selkoe, D. J., & Cotman, C. W. (1989) · Science · doi:10.1126/science.2928783 · Cited by 469
Self-citationIsolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease
Selkoe, D. J., Abraham, C. R., Podlisny, M. B., & Duffy, L. K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08501.x · Cited by 452
ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE
Candy, J., Klinowski, J., Perry, R. H., Perry, E. K., FAIRBAIRN, A. F., Oakley, A. E., Carpenter, T. A., Atack, J. R., Blessed, G., & Edwardson, J. A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92319-6 · Cited by 450
Dyrks, T., Weidemann, A., Multhaup, G., Salbaum, J. M., Lemaire, H.-G., Kang, J., Müller‐Hill, B., Masters, C. L., & Beyreuther, K. T. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02900.x · Cited by 394
Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease
Prelli, F., Castaño, E. M., Glenner, G. G., & Frangione, B. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01087.x · Cited by 351
Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.
Cataldo, A. M., & Nixon, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3861 · Cited by 340
Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1989) · PubMed Central · Cited by 335
Halverson, K. J., Fraser, P. E., Kirschner, D. A., & Lansbury, P. T. (1990) · Biochemistry · doi:10.1021/bi00463a003 · Cited by 292
YAMAGUCHI, H., Hirai, S., Morimatsu, M., Shoji, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00689591 · Cited by 283
MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE
Müller‐Hill, B., & Beyreuther, K. T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001443 · Cited by 264
Biochemistry of altered brain proteins in Alzheimer's disease.
Selkoe, D. (1989) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.12.030189.002335 · Cited by 261
Castaño, E. M., Ghiso, J. A., Prelli, F. C., Gorevic, P. D., Migheli, A., & Frangione, B. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80241-8 · Cited by 225
Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease
Wisniewski, H. M., Bancher, C., Barcikowska, M., Wen, G. Y., & Currie, J. (1989) · Acta Neuropathologica · doi:10.1007/bf00688170 · Cited by 220
Schubert, D. A., LaCorbiere, M., Saitoh, T., & Cole, G. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.2066 · Cited by 195
β-Amyloid protein promotes neuritic branching in hippocampal cultures
Whitson, J. S., Glabe, C. G., Shintani, E., Abcar, A. C., & Cotman, C. W. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90867-9 · Cited by 185
Self-citationJoachim, C. L., Duffy, L. K., Morris, J. H., & Selkoe, D. J. (1988) · Brain Research · doi:10.1016/0006-8993(88)90673-7 · Cited by 180
Cataldo, A. M., Thayer, C. Y., Bird, E. D., Wheelock, T. R., & Nixon, R. A. (1990) · Brain Research · doi:10.1016/0006-8993(90)90456-l · Cited by 176
Tanaka, S., Nakamura, S., Ueda, K., Kameyama, M., Shiojiri, S., Takahashi, Y., Kitaguchi, N., & Ito, H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80273-0 · Cited by 156
Gorevic, P. D., Castaño, E. M., Sarma, R., & Frangione, B. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91008-4 · Cited by 153
Alzheimer's disease: Its proteins and genes
Glenner, G. G. (1988) · Cell · doi:10.1016/s0092-8674(88)80021-7 · Cited by 149
Benowitz, L. I., Rodriguez, W. R., Paskevich, P. A., Mufson, E. J., Schenk, D., & Neve, R. L. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90156-8 · Cited by 140
Roher, A. E., WOLFE, D. E., Palutke, M., & Kukuruga, D. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2662 · Cited by 136
Evidence for lysosomal processing of amyloid ?-protein precursor in cultured cells
Cole, G. M., Huynh, T. V., & Saitoh, T. (1989) · Neurochemical Research · doi:10.1007/bf00965926 · Cited by 115
Maruyama, K., Terakado, K., Usami, M., & Yoshikawa, K. (1990) · Nature · doi:10.1038/347566a0 · Cited by 113
Prelli, F., Castaño, E. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80486-8 · Cited by 83
Molecular Genetics of Alzheimer's Disease and the Amyloid β Peptide Precursor Gene
Tanzi, R. E. (1989) · Annals of Medicine · doi:10.3109/07853898909149191 · Cited by 25
Prevention of aggregation of synthetic membrane-spanning peptides by addition of detergent
Tomich, J. M., Carson, L. W., Kanes, K. J., Vogelaar, N. J., Emerling, M. R., & Richards, J. H. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90535-0 · Cited by 18
Systemic and Cerebral Amyloidosis
Frangione, B. (1989) · Annals of Medicine · doi:10.3109/07853898909149186 · Cited by 15
Research works printed but not linked: 4
- Beyreuther, 1986, Discoveries Neurosci., 3, 68
- Glabe, 1990, Technique, 2, 138
- Joachim, 1989, Am. J. Pathol., 135, 309
- Masters, 1987, Ciba Found. Symp., 126, 49
Cited by
Sorted by citations
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
LeVine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,284
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
3D structure of Alzheimer's amyloid-β(1–42) fibrils
Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D. A., & Riek, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506723102 · Cited by 2,001
Metadata
- Authors
- Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C.
- Affiliations
- University of California, Irvine (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 267
- Issue
- 1
- Pages
- 546-554
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2130144581
- Cited by
- 1,014
- References
- 42
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 14 · 2023: 21 · 2022: 14 · 2021: 29 · 2020: 20 · 2019: 22 · 2018: 28 · 2017: 27 · 2016: 30 · 2015: 29 · 2014: 37 · 2013: 29 · 2012: 31
- FWCI
- 28.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r35ag007918-01, 5r01hd021379-14)
- National Institute on Aging (AG07918)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD21379)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- amyloid-beta, Alzheimer's disease, peptide analogues, amyloid fibril formation, peptide aggregation, solubility, pH dependence, Congo red staining, thioflavin T staining, amyloid plaques, hexafluoroisopropanol, amyloid deposition
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Amyloid, Chromatography, High Pressure Liquid, Electrophoresis, Polyacrylamide Gel, Hydrogen-Ion Concentration, Kinetics, Microscopy, Electron, Molecular Sequence Data, Peptides, Mass Spectrometry, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review